Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biosyent Inc (RX.VN)

Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 177,847
  • Shares Outstanding, K 11,263
  • Annual Sales, $ 35,031 K
  • Annual Income, $ 7,270 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.52
  • Price/Sales 4.33
  • Price/Cash Flow 22.42
  • Price/Book 4.46
  • Price/Earnings ttm 21.11
  • Earnings Per Share ttm 0.75
  • Most Recent Earnings $0.23 on 11/20/25
  • Next Earnings Date 03/12/26 [--]
  • Annual Dividend & Yield (Fwd) 0.22 (1.39%)
  • Most Recent Dividend 0.055 on 02/27/26
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Drug Specialty & Generic

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.14
  • Growth Rate Est. (year over year) +713,471.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.550 +25.42%
on 02/03/26
15.800 -0.38%
on 02/26/26
+3.240 (+25.92%)
since 02/02/26
3-Month
11.800 +33.39%
on 12/04/25
15.800 -0.38%
on 02/26/26
+3.910 (+33.05%)
since 12/02/25
52-Week
9.200 +71.09%
on 04/07/25
15.800 -0.38%
on 02/26/26
+4.540 (+40.54%)
since 02/28/25

Most Recent Stories

More News
Upcoming Meeting Dates - February 16, 2026

Toronto, Ontario--(Newsfile Corp. - February 16, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

ELY.VN : 0.120 (-4.00%)
CVE.TO : 31.25 (+2.83%)
LME.VN : 0.230 (+2.22%)
AAUC.TO : 43.08 (-0.23%)
NOA.TO : 23.10 (+1.14%)
ACQ.TO : 26.25 (-0.49%)
SCR.TO : 30.20 (+1.34%)
EQX.TO : 25.62 (+0.08%)
LUN.TO : 41.79 (-3.84%)
MSP.VN : 0.325 (+18.18%)
RCH.TO : 43.91 (+0.85%)
GLAB.CN : 0.0400 (unch)
Beyond the S&P 500: Finding Overlooked Opportunities in Small Caps

Large caps have outpaced small caps over the past year, with the S&P 500 up 16.4% versus 3.3% for the S&P 600, driven by sector weightings and concentration in mega-cap tech like Nvidia. Small caps lagged...

NFLX : 97.09 (+0.88%)
NVDA : 182.48 (+2.99%)
AAPL : 264.72 (+0.20%)
MP : 63.73 (+8.26%)
T : 28.01 (unch)
LYV : 161.81 (-0.20%)
CNC : 44.60 (-0.62%)
TTGT : 3.58 (+1.99%)
SATS : 118.68 (+2.73%)
RX.VN : 15.740 (-0.32%)
UNH : 294.93 (+0.57%)
BioSyent to Present at LD Micro New York Investor Conference

Mississauga, Ontario--(Newsfile Corp. - April 4, 2025) - BioSyent Inc. (TSXV: RX) ("BioSyent" or the "Company") announces that Mr. René Goehrum, President and CEO of BioSyent, will be presenting in person...

BIOYF : 11.4000 (+0.14%)
RX.VN : 15.740 (-0.32%)
BioSyent Releases Financial Results for Q1 2022

MISSISSAUGA, Ontario, May 18, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three...

RX.VN : 15.740 (-0.32%)
BioSyent Schedules Q1 2022 Earnings Release for May 18, 2022

MISSISSAUGA, Ontario, May 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results...

RX.VN : 15.740 (-0.32%)
BioSyent to Present at 2022 Bloom Burton & Co. Healthcare Investor Conference

MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at...

RX.VN : 15.740 (-0.32%)
BioSyent Announces Grant of Restricted Share Units

MISSISSAUGA, Ontario, March 31, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of...

RX.VN : 15.740 (-0.32%)
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2021

MISSISSAUGA, Ontario, March 09, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three...

RX.VN : 15.740 (-0.32%)
BioSyent Schedules Q4 and Full Year 2021 Earnings Release for March 9, 2022

MISSISSAUGA, Ontario, March 03, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial...

RX.VN : 15.740 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

See More

Key Turning Points

3rd Resistance Point 15.993
2nd Resistance Point 15.867
1st Resistance Point 15.803
Last Price 15.740
1st Support Level 15.613
2nd Support Level 15.487
3rd Support Level 15.423

See More

52-Week High 15.800
Last Price 15.740
Fibonacci 61.8% 13.279
Fibonacci 50% 12.500
Fibonacci 38.2% 11.721
52-Week Low 9.200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar